drugset / Trial / NCT04309916

Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

NCT04309916

Phase 4 Completed 46 enrolled HK inno.N Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to compare the nighttime heartburn and sleep disturbance improvement effect of Tegoprazan 50mg and Eomeprazole 40mg in patients with ERD patients.

Timeline

Start
2020-05-22
Primary completion
2021-11-30
Completion
2021-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esomeprazole Small molecule 40 mg Oral
Subject Tegoprazan Other / unclassified 50 mg Oral